CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 11.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,072,457 | -85.5% | 176,173 | -85.8% | 0.10% | -85.9% |
| Q1 2024 | $21,144,340 | +67.2% | 1,240,865 | 0.0% | 0.68% | +46.8% |
| Q4 2023 | $12,644,414 | -26.8% | 1,240,865 | -35.0% | 0.46% | -15.0% |
| Q3 2023 | $17,275,228 | -15.9% | 1,908,865 | 0.0% | 0.55% | -18.6% |
| Q2 2023 | $20,539,387 | – | 1,908,865 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |